Molecular mechanism and structure-guided humanization of a broadly neutralizing antibody against SFTSV
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012550 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Pinyi Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences, Nankai University, Tianjin, China. Hauptthemen laut MEDLINE: Antibodies, Viral, Phlebovirus, Antibodies, Neutralizing. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Project of Guangzhou National Laboratory, China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Severe fever with thrombocytopenia syndrome virus (SFTSV) is a novel tick-borne bunyavirus that causes severe fever with thrombocytopenia syndrome (SFTS), with a high mortality rate of up to 30%. The envelope glycoproteins of SFTSV, glycoprotein N (Gn) and glycoprotein C (Gc), facilitate the recognition of host receptors and the process of membrane fusion, allowing the virus to enter host cells. We previously reported a monoclonal antibody, mAb 40C10, capable of neutralizing different genotypes of SFTSV and SFTSV-related viruses. However, the specific neutralization mechanism is poorly understood. In this study, we elucidated the high-resolution structure of the SFTSV Gn head domain in complex with mAb 40C10, confirming that the binding epitope in the domain I region of SFTSV Gn, and it represented that a novel binding epitope of SFTSV Gn was identified. Through in-depth structural and sequence analyses, we found that the binding sites of mAb 40C10 are relatively conserved among different genotypes of SFTSV and SFTSV-related Heartland virus and Guertu virus, elucidating the molecular mechanism underlying the broad-spectrum neutralizing activity of mAb 40C10. Furthermore, we humanized of mAb 40C10, which is originally of murine origin, to reduce its immunogenicity. The resulting nine humanized antibodies maintained potent affinity and neutralizing activity. One of the humanized antibodies exhibited neutralizing activity at picomolar IC 50 values and demonstrated effective therapeutic and protective effects in a mouse infection model. These findings provide a novel target for the future development of SFTSV vaccines or drugs and establish a foundation for the research and development of antibody therapeutics for clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences, Nankai University, Tianjin, China.
- Key Laboratory of Virology and Biosafety and National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.
- Guangzhou National Laboratory, Guangzhou, Guangdong, China.
- Hangzhou Medimscience Biomedical Technology Co., Ltd., Hangzhou, Zhejiang, China.
Förderung
- Major Project of Guangzhou National Laboratory
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Foundation of State Key Laboratory of Component-based Chinese Medicine
- Fundamental Research Funds for the Central Universities, Nankai University
Zitieren
APA
Yang, P., Wu, X., Shang, H., Sun, Z., Wang, Z., Song, Z., Yuan, H., Deng, F., Shen, S., Guo, Y., & Zhang, N. (2024). Molecular mechanism and structure-guided humanization of a broadly neutralizing antibody against SFTSV. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012550
Vancouver
Yang P, Wu X, Shang H, Sun Z, Wang Z, Song Z, et al. Molecular mechanism and structure-guided humanization of a broadly neutralizing antibody against SFTSV. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012550
BibTeX
@article{Yang2024,
author = {Yang, Pinyi and Wu, Xiaoli and Shang, Hang and Sun, Zixian and Wang, Zhiying and Song, Zidan and Yuan, Hong and Deng, Fei and Shen, Shu and Guo, Yu and Zhang, Nan},
title = {Molecular mechanism and structure-guided humanization of a broadly neutralizing antibody against SFTSV},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012550}
}
EUVIMED